Effect of the dynamic curve type from the perifocal infiltration zone obtained by magnetic resonance imaging on prognosis in pelvic pathologies in women

The aim of the study is to evaluate the role and prognostic significance of magnetic resonance imaging (MRI) perfusion methods in prognosis of disease course and outcome based on evaluation of the perifocal infiltration zone in pelvic disorders in women.

Materials and methods. Retrospective analysis of pelvic MRI data obtained using MRI system with induced magnetic field of 1.5 T was performed. The study included 530 protocols of pelvic scans in women. Two equal groups (n = 265) of patients with oncological and nononcological pathologies of pelvic organs were formed; after application of propensity score matching, each group contained 165 patients. All examination protocols included dynamic contrast enhancement. The obtained data were statistically analyzed using the Stata 13 software.

Results. In the study, types of dynamic curves obtained using dynamic contrast enhancement from the perifocal infiltration zone were analyzed. There was no data showing a correlation between the type of dynamic curve from the zone of perifocal changes and disease prognosis or possibility of differential diagnosis.

Conclusions. Evaluation of the perifocal infiltration zone per MRI results with intravenous contrast does not affect prognostic accuracy of the method (p >0.05); contrast can be used only for differential diagnosis or evaluation of local advancement of the process.

1. Daun M., Fardin S., Ushinsky A. et al. PIRADS version 2 is an excellent screening tool for clinically significant prostate cancer as designated by the Validated International Society of Urological Pathology Criteria: a retrospective analysis. Curr Probl Diagn Radiol 2019. DOI: 10.1067/j.cpradiol. 2019.06.010.

2. Zhang X., Pang H., Dong Y. et al. A study of dynamic contrast-enhanced MR imaging features and influence factors of pelvic bone marrow in adult females. Osteoporos Int 2019;30(12):2469–76. DOI: 10.1007/s00198-019-05145-w.

3. Li H.M., Qiang J.W., Ma F.H., Zhao S.H. The value of dynamic contrast – enhanced MRI in characterizing complex ovarian tumors. J Ovarian Res 2017;10(1):4. DOI: 10.1186/s13048-017-0302-y.

4. Thieme S.F., Collettini F., Sehouli J. et al. Preoperative evaluation of myometrial invasion in endometrial carcinoma: prospective intra-individual comparison of magnetic resonance volumetry, diffusion-weighted and dynamic contrastenhanced magnetic resonance imaging. Anticancer Res 2018;38(8):4813–7. DOI: 10.21873/anticanres. 12791.

5. Poncelet E., Delpierre C., Kerdraon O. et al. Value of dynamic contrast-enhanced MRI for tissue characterization of ovarian teratomas: correlation with histopathology. Clin Radiol 2013;68 (9):909–16. DOI: 10.1016/j.crad. 2013.03.029.

6. Long A.G., Lundsmith E.T., Hamilton K.E. Inflammation and colorectal cancer. Curr Colorectal Cancer Rep 2017;13(4):341–51. DOI: 10.1007/s11888-017-0373-6.

7. Nougaret S., Horta M., Sala E. et al. Endometrial cancer MRI staging: updated guidelines of the European Society of urogenital radiology. Eur Radiol 2019;29(2):792–805. DOI: 10.1007/s00330-018-5515-y.

8. Thomassin-Naggara I., Siles P., Balvay D. et al. MR perfusion for pelvic female imaging. Diagn Interv Imaging 2013; 94(12):1291–8. DOI: 10.1016/j.diii.2013.06.004.

9. Gity M., Parviz S., Saligheh Rad H. et al. Differentiation of benign from malignant adnexal masses by dynamic contrast-enhanced MRI (DCE-MRI): quantitative and semi-quantitative analysis at 3-Tesla MRI. Asian Pac J Cancer Prev 2019;20(4):1073–9. DOI: 10.31557/APJCP.2019.20.4.1073.